업데이트됨
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
감염병학 2025의료 권고사항
임상 권고사항
의학회 및 보건 당국이 발표한 공식 권고사항, 합의문 및 업데이트를 확인하세요.
공식적이고 신뢰할 수 있는 출처의학회 및 보건 당국
최신 정보지속적인 과학적 모니터링
전문가를 위한 무료 이용의료 커뮤니티를 지원합니다
주요 간행물 및 업데이트
최근 발행물 보기
업데이트됨
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
심장학 2025
공식 발행
WHO guidelines on the integrated management of obesity in adolescents
World Health Organization
소아과학 2026모든 권고사항 (결과 524개)
필터
Archived 41: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada [2022-06-29]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 41: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program i...
Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COV...
Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age [2022-07-14]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 year...
Archived 43: Summary of NACI statement of August 19, 2022: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 43: Summary of NACI statement of August 19, 2022: Recommendations on the use of a first booster do...
Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vacci...
Archived 44: Summary of NACI statement: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 44: Summary of NACI statement: Updated guidance on COVID-19 vaccines for individuals who are pregn...
Archived 44: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding [2022-09-09]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 44: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding [2022-...
Archived 45: Summary of NACI statement of October 7, 2022: Updated guidance on COVID-19 vaccine booster doses in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 45: Summary of NACI statement of October 7, 2022: Updated guidance on COVID-19 vaccine booster dos...
Archived 45: Updated guidance on COVID-19 vaccine booster doses in Canada [2022-10-07]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 45: Updated guidance on COVID-19 vaccine booster doses in Canada [2022-10-07]”. Updated guidance o...
Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech C...